Hypertension, a condition characterized by consistently high blood pressure, affects over a billion people worldwide and remains a leading cause of cardiovascular disease, kidney failure, and stroke. Despite significant progress in treatment, many patients fail to achieve optimal blood pressure control due to medication resistance, side effects, or limited therapeutic options. Recent advancements in hypertension drugs, including the development of angiotensin blockers and novel therapeutic approaches, are transforming the landscape of hypertension management. This article explores the evolution of pharmaceutical options for hypertension, highlighting recent innovations and their potential to improve outcomes.
